Evoke Pharma, Inc.
EVOK
EVOK: Evoke Pharma Inc is a specialty pharmaceutical company focused on the development of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
moreShow EVOK Financials
Recent trades of EVOK by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by EVOK's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Nasal formulations of metoclopramide Apr. 18, 2023
-
Patent Title: Treatment of moderate and severe gastroparesis Dec. 06, 2022
-
Patent Title: Nasal formulations of metoclopramide Jun. 01, 2021
-
Patent Title: Nasal formulations of metoclopramide Dec. 18, 2012
Federal grants, loans, and purchases
Followers on EVOK's company Twitter account
Number of mentions of EVOK in WallStreetBets Daily Discussion
Recent insights relating to EVOK
Recent picks made for EVOK stock on CNBC
ETFs with the largest estimated holdings in EVOK
Flights by private jets registered to EVOK